Contact this trialFirst, we need to learn more about you.
Anti-fibrotic Agent
ENV-101 for Pulmonary Fibrosis
Recruiting0 awardsPhase 2
Philadelphia, Pennsylvania
This trial aims to see how a drug called ENV-101 affects lung function and fibrosis in adults with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). It
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service